185 related articles for article (PubMed ID: 17405776)
1. Routine thrombolysis with intravenous tissue plasminogen activator in acute ischaemic stroke patients aged 80 years or older: a single centre experience.
Uyttenboogaart M; Schrijvers EM; Vroomen PC; De Keyser J; Luijckx GJ
Age Ageing; 2007 Sep; 36(5):577-9. PubMed ID: 17405776
[No Abstract] [Full Text] [Related]
2. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
[TBL] [Abstract][Full Text] [Related]
3. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy.
Toni D; Lorenzano S; Agnelli G; Guidetti D; Orlandi G; Semplicini A; Toso V; Caso V; Malferrari G; Fanucchi S; Bartolomei L; Prencipe M
Cerebrovasc Dis; 2008; 25(1-2):129-35. PubMed ID: 18073466
[TBL] [Abstract][Full Text] [Related]
4. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
5. Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis.
Maiser SJ; Georgiadis AL; Suri MF; Vazquez G; Lakshminarayan K; Qureshi AI
Int J Stroke; 2011 Feb; 6(1):25-32. PubMed ID: 21205237
[TBL] [Abstract][Full Text] [Related]
6. Thrombolysis 3 to 4.5 hours after acute ischemic stroke.
Fitzpatrick AE; Noone I; O'Shea DD
N Engl J Med; 2008 Dec; 359(26):2840; author reply 2841. PubMed ID: 19115491
[No Abstract] [Full Text] [Related]
7. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
[TBL] [Abstract][Full Text] [Related]
8. [Can the target group for thrombolysis in acute ischemic stroke be widened? Current indication is very narrow--new study results are necessary].
Murray V
Lakartidningen; 2011 Jan 12-18; 108(1-2):16-7. PubMed ID: 21365808
[No Abstract] [Full Text] [Related]
9. Intra-arterial thrombolysis after full-dose intravenous recombinant tissue plasminogen activator for patients older than 80 years with acute ischemic stroke: what is the safety limit?
Pieri A; Spitz M; Kihara EN; Gabbai AA
Neurol India; 2010; 58(3):487. PubMed ID: 20644289
[No Abstract] [Full Text] [Related]
10. Feasibility and safety of intravenous thrombolysis for acute ischaemic stroke in northern Greece.
Rudolf J; Tsivgoulis G; Deretzi G; Heliopoulos I; Vadikolias K; Tsiptsios I; Piperidou C
Int J Stroke; 2011 Feb; 6(1):91-2. PubMed ID: 21205250
[No Abstract] [Full Text] [Related]
11. Thrombolysis 3 to 4.5 hours after acute ischemic stroke.
Schwamm LH; Fonarow GC
N Engl J Med; 2008 Dec; 359(26):2840; author reply 2841. PubMed ID: 19115490
[No Abstract] [Full Text] [Related]
12. Thrombolysis 3 to 4.5 hours after acute ischemic stroke.
Morris DC
N Engl J Med; 2008 Dec; 359(26):2841; author reply 2841. PubMed ID: 19115492
[No Abstract] [Full Text] [Related]
13. Intravenous thrombolysis with rt-PA in acute stroke patients aged >or=80 years.
Toni D; Lorenzano S
Int J Stroke; 2009 Feb; 4(1):21-2. PubMed ID: 19236493
[No Abstract] [Full Text] [Related]
14. Influence of gender on outcomes after intra-arterial thrombolysis for acute ischemic stroke.
Shah SH; Liebeskind DS; Saver JL; Starkman S; Vinuela F; Duckwiler G; Jahan R; Kim D; Sanossian N; Vespa P; Ovbiagele B
Neurology; 2006 Jun; 66(11):1745-6. PubMed ID: 16769954
[TBL] [Abstract][Full Text] [Related]
15. Thrombolysis 3 to 4.5 hours after acute ischemic stroke.
Torbey MT; Jauch E; Liebeskind DS;
N Engl J Med; 2008 Dec; 359(26):2839; author reply 2841. PubMed ID: 19109580
[No Abstract] [Full Text] [Related]
16. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences?
Allen NB; Myers D; Watanabe E; Dostal J; Sama D; Goldstein LB; Lichtman JH
Cerebrovasc Dis; 2009; 27(3):254-8. PubMed ID: 19176959
[TBL] [Abstract][Full Text] [Related]
17. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes.
Fonarow GC; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Grau-Sepulveda MV; Olson DM; Hernandez AF; Peterson ED; Schwamm LH
Circulation; 2011 Feb; 123(7):750-8. PubMed ID: 21311083
[TBL] [Abstract][Full Text] [Related]
18. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke in a patient treated with rivaroxaban.
van Hooff RJ; Nieboer K; De Smedt A; Yperzeele L; Jochmans K; De Keyser J; Brouns R
Clin Neurol Neurosurg; 2014 Jul; 122():133-4. PubMed ID: 24813326
[No Abstract] [Full Text] [Related]
19. Effectiveness of thrombolysis with intravenous alteplase for acute ischemic stroke in older adults.
Dirks M; Koudstaal PJ; Dippel DW; Niessen LW; van Wijngaarden JD; Franke CL; van Oostenbrugge RJ
J Am Geriatr Soc; 2011 Nov; 59(11):2169-71. PubMed ID: 22098036
[No Abstract] [Full Text] [Related]
20. Treatment results of stroke patients aged >80 years receiving intravenous rt-PA.
Jauss M; Allendorfer J; Stolz E; Schutz HJ; Misselwitz B
Cerebrovasc Dis; 2007; 24(2-3):305-6. PubMed ID: 17646696
[No Abstract] [Full Text] [Related]
[Next] [New Search]
